The Changing Diabetes® Leadership Initiative is part of Novo Nordisk’s commitment to facilitating a worldwide response to the escalating diabetes pandemic. The global initiative was established following the United Nations’ (UN) adoption of a Resolution on diabetes [No 61/225 of 20 December 2006], which calls upon all nations to take appropriate action.

As a central part of the Changing Diabetes® initiative, Novo Nordisk collaborates with multiple partners to hold international, regional and national Leadership Forums. The role of Novo Nordisk is generally that of sponsor and co-organiser, and titles and themes vary according to the partnership set-up and local priorities. The Forums are unique opportunities for public health stakeholders to host or support high-level advocacy meetings to bring issues related to diabetes and non-communicable diseases on the political agenda and commit to sustainable action in the areas of prevention of diabetes and its complications, early detection and improved care for people with diabetes.

The Forums aim to facilitate united responses on national level and across regions, and gather policy-makers, international health organisations, diabetes associations, healthcare professionals, businesses, media, actors from outside the health community and others. From 2007 to 2011, Leadership Forums have taken place in more than 20 locations worldwide, with international Forums in New York, Moscow, Beijing, Johannesburg and Dubai.


For more information about the Changing Diabetes® Leadership Initiative and Forums and opportunities for partnerships, please contact:

Niels Lund
Global Public Affairs
+45 30 79 78 70



The books demonstrate how investments in diabetes can impact macroeconomic development and growth as well as bring down the human suffering caused by the diabetes epidemic:


  • Algeria (November 2008)
  • Australia (October 2006; August 2007; 2008)
  • Belgium (November 2008)
  • Bulgaria (February 2008; November 2009)
  • Denmark (April 2008; September 2010; April 2012)
  • Egypt (2006; 2007; 2008; 2009)
  • Finland (April 2010)
  • France (April 2009)
  • Germany (October 2009; March 2010)
  • Hungary (September 2009; 2010)
  • Italy (2008; April 2009; March 2010)
  • The Netherlands (June 2007; May 2008)
  • Russia (St Petersburg regional Forum, November 2009)
  • Spain (November 2009)
  • Spain (Canary Islands regional Forum, November 2009)
  • Turkey (2007)

International Leadership Forums

The European Diabetes Leadership Forum (EDLF)
Copenhagen, 25-26 April 2012

The European Diabetes Leadership Forum took place on 25 and 26 April 2012 in Copenhagen, Denmark. The Forum brought together more than 700 diabetes experts, decision- and policy-makers as well as representatives from NGOs, patient associations, academia and industry, from over 55 countries. The Forum was hosted by the Organisation for Economic Cooperation and Development (OECD) and the Danish Diabetes Association. It was held under the auspices of the Danish Presidency of the Council of the European Union and the Danish Ministry of Health, and supported by Novo Nordisk.



Middle East and Northern Africa (MENA) Diabetes Leadership Forum
Dubai, UAE, 12-13 December 2010

400 policy- and decision-makers from 22 countries gathered at this Forum to explore and design solutions around diabetes awareness, prevention and lifestyle interventions, quality of diabetes care, and systems to effectively reduce the economic burden of diabetes in the MENA region. The Forum was organised under the high patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai and Finance Minister of the UAE, co-hosted by the UAE Ministry of Health, the executive board of the Health Ministers’ Council for Cooperation Council States, the World Diabetes Foundation and the World Bank, and supported by a wide range of leading health organisations including the International Diabetes Federation and the World Health Organization.



Diabetes Leadership Forum Africa 2010
Johannesburg, South Africa, September-October 2010

More than 260 participants representing multiple stakeholders from 32 countries across sub-Saharan Africa discussed measures to strengthen health systems, integrate control of NCDs into current initiatives to fight infectious diseases, and identified practical and innovative approaches to develop appropriate responses to the health challenges in the region. The Forum as jointly hosted by the Department of Health of the Republic of South Africa and the World Diabetes Foundation with the support of the International Diabetes Federation.



Diabetes Leadership Forum 2009 China
Beijing, China, October 2009

Around 650 participants from China and abroad discussed how to ensure better maternal health, diabetes education, the role of media, community management in chronic care and cross-sector cooperation. The Forum was hosted by the Chinese Ministry of Health and the World Diabetes Foundation, co-organised by the Chinese Diabetes Society and the Chinese Centre for Disease Control and Prevention and supported by the International Diabetes Federation.


International Forum ‘Unite to Change Diabetes’
Moscow, Russia, November 2008

The Moscow Forum drew attention to the threat posed by diabetes in Russia and its serious social and economic consequences. The Forum was attended by over 300 delegates from across the Russian Federation and abroad and was hosted by the Russian Diabetes Federation with the support of the IDF.


Global Changing Diabetes® Leadership Forum
New York City, March 2007

Novo Nordisk hosted the first in the series of Leadership Forums. The objective was to spark a worldwide change in diabetes care by sharing knowledge and committing to national follow-up Forums in the more than 20 countries represented.


In New York, Lars Rebien Sørensen, president and CEO of Novo Nordisk, announced the company’s plans to develop a Changing Diabetes® Barometer to provide guidance for decision-makers to measure progress on diabetes outcomes and help set priorities for national diabetes action plans. The Barometer’s philosophy of measure-share-improve is aligned with Novo Nordisk’s belief that monitoring outcomes is essential to identify best practices and guide sustainable actions.